North America Epigenetics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)

The North America Epigenetics Market is segmented By Product (Instruments, Reagents & Kits, Others), By Application, By Technology and Geography.

North America Epigenetics Market Size

Market Snapshot
Study Period: 2018 - 2028
CAGR: 20 %

Major Players


*Disclaimer: Major Players sorted in no particular order


Need a report that reflects how COVID-19 has impacted this market and it's growth?

North America Epigenetics Market Analysis

The North America Epigenetics Market is expected to register a 20% of CAGR growth during the forecast period. The key contributor to the market is the growing burden of cancer and increasing investments into research and development activities. 

According to the American Cancer Society, in 2020, around 1.8 million new cases will be diagnosed in the United States and about 606,520 people are expected to die due to it. Epigenetics modifications can influence the cellular responses with respect to the apoptosis, cell proliferation and senescence. 

Hence, epigenetics has a very crucial role in cancer treatment and thereby it is expected to boost the market growth over the forecast period.

North America Epigenetics Industry Segmentation

Epigenetics refers to the study of genetic controlling by factors except the DNA sequencing of an individual. It majorly deals with the gene expression. The North America Epigenetics Market is segmented By Product, By Application, By Technology and Geography.

By Product
Reagents & Kits
By Applications
Autoimmune Diseases
Metabollic Diseases
CNS/Pain Diseases
Cardiovascular Diseases
By Technology
By Geography
North America
United States

Report scope can be customized per your requirements. Click here.

North America Epigenetics Market Trends

This section covers the major market trends shaping the North America Epigenetics Market according to our research experts:

Cardiovascular Diseases are Expected to Show a Steady Growth in the North America Epigenetics Market

Cardiovascular diseases are expected to show steady growth in the market during the forecast period. Recent studies have shown that epigenetics has a very significant role in cardiovascular diseases. The information of epigenetics can help in determining the response of an individual towards the drug. In addition, it can also be developed to assess the risk determinants for cardiovascular diseases. Hence, it can be a diagnosis and prognosis of cardiovascular diseases. Heart diseases are one of the leading cause of death in the United States. As per the Centre for Disease Control and Prevention, one person dies in every 37 seconds in America due to cardiovascular disease. 

Furthermore, the increasing investments into R&D are expected to impact positively on the market. According to the Pharmaceutical Research and Manufacturers of America (PhRMA), 2018, around USD 79.6 billion were spent on the research and development activities. Thus, the aforementioned factors are expected to impact positively on the market in this segment.

Cell Surface Markers Detection Trend Image.png

North America Epigenetics Industry Overview

The key players in the North America Epigenetics market are Abcam PLC, Active Motiff, Diagenode Inc., F. Hoffmann-La Roche Ltd, Illumina Inc., Qiagen N.V., Merck & Co. Inc., ThermoFisher Scientific and Zyhmo Research Corporation.

North America Epigenetics Market Leaders

  1. Diagenode Inc.

  2. Merck KGaA

  3. Illumina Inc.

  4. Active Motiff

  5. Abcam Plc

*Disclaimer: Major Players sorted in no particular order

NA Epigentics Market Concentration.png

North America Epigenetics Market Report - Table of Contents


    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Burden of Cancer Diseases

      2. 4.2.2 Increasing Investments into Research and Development Activities

      3. 4.2.3 Rising Epigenetic Applications in Non-oncology Diseases

    3. 4.3 Market Restraints

      1. 4.3.1 Presence of Stringent Regulatory Framework

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Product

      1. 5.1.1 Instruments

      2. 5.1.2 Reagents & Kits

      3. 5.1.3 Others

    2. 5.2 By Applications

      1. 5.2.1 Oncology

      2. 5.2.2 Autoimmune Diseases

      3. 5.2.3 Metabollic Diseases

      4. 5.2.4 CNS/Pain Diseases

      5. 5.2.5 Cardiovascular Diseases

      6. 5.2.6 Others

    3. 5.3 By Technology

      1. 5.3.1 Methylation

      2. 5.3.2 Acetylation

      3. 5.3.3 Phosphorylation

      4. 5.3.4 Others

    4. 5.4 By Geography

      1. 5.4.1 North America

        1. United States

        2. Canada

        3. Mexico


    1. 6.1 Company Profiles

      1. 6.1.1 Abcam PLC

      2. 6.1.2 Active Motiff

      3. 6.1.3 Diagenode Inc.

      4. 6.1.4 F. Hoffmann-La Roche Ltd

      5. 6.1.5 Illumina Inc.

      6. 6.1.6 Qiagen N.V.

      7. 6.1.7 Merck KGaA

      8. 6.1.8 TherFisher Scientific

      9. 6.1.9 Zyhmo Research Corporation

    2. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You can also purchase parts of this report. Do you want to check out a section wise price list?

North America Epigenetics Market Research FAQs

The North America Epigenetics Market is studied from 2018 - 2028.

The North America Epigenetics Market is growing at a CAGR of 20% over the next 5 years.

Diagenode Inc., Merck KGaA, Illumina Inc., Active Motiff, Abcam Plc are the major companies operating in North America Epigenetics Market.

North America Epigenetics Industry Report

Statistics for the 2023 North America Epigenetics market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. North America Epigenetics analysis includes a market forecast outlook to 2028 and historical overview. Get a sample of this industry analysis as a free report PDF download.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!